Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-01

Clinical Trial Update: Evaluation of Symptom-specific Goal Achievement [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating symptom-specific goal achievement in benign prostatic hyperplasia and lower urinary tract symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Samsung Medical Center | Conditions: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 4 | Status: COMPLETED